While these factors may have been linked to increased risk of breast cancer, future studies are needed to determine whether these modifiable and non-modifiable factors affect somatic molecular biology of, and survival in, women with HR+/HER2-breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.